Imamura, T., Komatsu, S., Ichikawa, D., Miyamae, M., Okajima, W., Ohashi, T., . . . Otsuji, E. (2017). Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer. Nature Portfolio.
Chicago Style (17th ed.) CitationImamura, Taisuke, et al. Depleted Tumor Suppressor MiR-107 in Plasma Relates to Tumor Progression and Is a Novel Therapeutic Target in Pancreatic Cancer. Nature Portfolio, 2017.
MLA (8th ed.) CitationImamura, Taisuke, et al. Depleted Tumor Suppressor MiR-107 in Plasma Relates to Tumor Progression and Is a Novel Therapeutic Target in Pancreatic Cancer. Nature Portfolio, 2017.
Warning: These citations may not always be 100% accurate.